ACHV
Price
$2.18
Change
-$0.08 (-3.54%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
108.31M
35 days until earnings call
EYPT
Price
$9.72
Change
+$0.06 (+0.62%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
668.85M
26 days until earnings call
Interact to see
Advertisement

ACHV vs EYPT

Header iconACHV vs EYPT Comparison
Open Charts ACHV vs EYPTBanner chart's image
Achieve Life Sciences
Price$2.18
Change-$0.08 (-3.54%)
Volume$39.2K
Capitalization108.31M
EyePoint Pharmaceuticals
Price$9.72
Change+$0.06 (+0.62%)
Volume$44.38K
Capitalization668.85M
ACHV vs EYPT Comparison Chart in %
Loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACHV vs. EYPT commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Hold and EYPT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (ACHV: $2.18 vs. EYPT: $9.72)
Brand notoriety: ACHV and EYPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 122% vs. EYPT: 44%
Market capitalization -- ACHV: $108.31M vs. EYPT: $668.85M
ACHV [@Biotechnology] is valued at $108.31M. EYPT’s [@Biotechnology] market capitalization is $668.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileEYPT’s FA Score has 1 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • EYPT’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than ACHV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 4 TA indicator(s) are bullish while EYPT’s TA Score has 4 bullish TA indicator(s).

  • ACHV’s TA Score: 4 bullish, 5 bearish.
  • EYPT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ACHV and EYPT are a bad buy in the short-term.

Price Growth

ACHV (@Biotechnology) experienced а -37.89% price change this week, while EYPT (@Biotechnology) price change was -6.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ACHV is expected to report earnings on Aug 07, 2025.

EYPT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($669M) has a higher market cap than ACHV($108M). EYPT YTD gains are higher at: 30.470 vs. ACHV (-38.068). ACHV has higher annual earnings (EBITDA): -44.37M vs. EYPT (-144.55M). EYPT has more cash in the bank: 318M vs. ACHV (23.2M). ACHV has less debt than EYPT: ACHV (9.96M) vs EYPT (24.1M). EYPT has higher revenues than ACHV: EYPT (56M) vs ACHV (0).
ACHVEYPTACHV / EYPT
Capitalization108M669M16%
EBITDA-44.37M-144.55M31%
Gain YTD-38.06830.470-125%
P/E RatioN/AN/A-
Revenue056M-
Total Cash23.2M318M7%
Total Debt9.96M24.1M41%
FUNDAMENTALS RATINGS
ACHV vs EYPT: Fundamental Ratings
ACHV
EYPT
OUTLOOK RATING
1..100
5369
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
9337
P/E GROWTH RATING
1..100
10017
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EYPT's Valuation (61) in the Pharmaceuticals Major industry is in the same range as ACHV (71) in the Biotechnology industry. This means that EYPT’s stock grew similarly to ACHV’s over the last 12 months.

EYPT's Profit vs Risk Rating (98) in the Pharmaceuticals Major industry is in the same range as ACHV (100) in the Biotechnology industry. This means that EYPT’s stock grew similarly to ACHV’s over the last 12 months.

EYPT's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as ACHV (99) in the Biotechnology industry. This means that EYPT’s stock grew similarly to ACHV’s over the last 12 months.

EYPT's Price Growth Rating (37) in the Pharmaceuticals Major industry is somewhat better than the same rating for ACHV (93) in the Biotechnology industry. This means that EYPT’s stock grew somewhat faster than ACHV’s over the last 12 months.

EYPT's P/E Growth Rating (17) in the Pharmaceuticals Major industry is significantly better than the same rating for ACHV (100) in the Biotechnology industry. This means that EYPT’s stock grew significantly faster than ACHV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHVEYPT
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CBLLX11.04N/A
N/A
Allspring Large Cap Value Admin
HRCCX29.60N/A
N/A
Carillon ClariVest Capital Apprec C
SGPSX80.75N/A
N/A
ProFunds Small Cap Growth Svc
FGFRX43.10N/A
N/A
Federated Hermes Intl Leaders R
JHBCX65.31N/A
N/A
JHancock Blue Chip Growth NAV

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with ABOS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-3.54%
ABOS - ACHV
41%
Loosely correlated
+2.65%
GLSI - ACHV
38%
Loosely correlated
+1.52%
EYPT - ACHV
37%
Loosely correlated
+0.62%
PDSB - ACHV
37%
Loosely correlated
+4.72%
ARCT - ACHV
37%
Loosely correlated
+1.17%
More